Drugs / compound tripterygium
last change Dec 2016 re-read 3 minutes ago

compound tripterygium

Developed for
rheumatoid arthritis
Investigated by
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01961505 Oct 2011 → Sep 2015 rheumatoid arthritis Guang'anmen Hospital of China Academy of Chinese Medical Sciences Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as compound tripterygium ClinicalTrials.gov intervention name — accepted as the source's own label NCT01961505 ↗
Route Topical “Topical compound tripterygium was applied for the pain and swollen joints on non-woven fabric for 1 hour, twice per day.” NCT01961505 ↗